# Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial

> Research article (JID Innovations, 2022) · cited 24× · AI/ML

**Wikidata**: [openalex:W4294883918](https://www.wikidata.org/wiki/openalex:W4294883918)  
**Source**: https://4ort.xyz/entity/safety-and-efficacy-of-ritlecitinib-and-brepocitinib-in-alopecia-areata-results-from-the-crossover-open-label-extension-